EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Export of generic medicines to developing countries: compulsory licences
Export of generic medicines to developing countries: compulsory licences
Export of generic medicines to developing countries: compulsory licences
Export of generic medicines to developing countries: compulsory licences
SUMMARY OF:
SUMMARY
WHAT DOES THIS REGULATION DO?
It establishes a procedure for companies in the EU wishing to manufacture generic medicines for use in the developing world to apply for a compulsory licence from a patent holder, which allows their manufacture.
KEY POINTS
FROM WHEN DOES THE REGULATION APPLY?
It entered into force on 29 June 2006.
BACKGROUND
The legislation is part of wider EU action to tackle public-health concerns that the world’s least developed and developing countries face, in particular access to safe, effective and affordable medicines.
ACT
Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems (OJ L 157, 9.6.2006, pp. 1-7)
last update 16.02.2016